Potential application of neogalactosylalbumin in positron emission tomography evaluation of liver function

Figure 1 [¹⁸F]FNGA distribution in both control and fibrosis mice at various time points. Relative radioactivity levels are shown at various time points from organs of control mice (n = 21) (A) and CCl₄-induced fibrosis mice (n = 23) (B). ^bP < 0.01 vs Liver, ^aP < 0.05 vs Liver, ^eP < 0.001 vs Liver. [¹⁸F]FNGA: ¹⁸F-labeled neogalactosylalbumin.